The DSHEA Act and Peptides: Are Peptides Dietary Supplements?

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Are peptides dietary supplements? This comprehensive article explores the complex legal landscape of the DSHEA Act and its relationship with peptides. Learn about the FDA's stance on synthetic peptides and how to navigate the market safely.

The DSHEA Act and Peptides: A Complex Regulatory Landscape

In the ever-expanding world of health and wellness, peptides have emerged as a popular topic of discussion, with promises of benefits ranging from anti-aging to muscle growth. This has led many to wonder, are peptides dietary supplements? The answer, however, is not a simple yes or no. It lies within the intricate legal framework of the Dietary Supplement Health and Education Act of 1994 (DSHEA), a piece of legislation that fundamentally shaped the supplement industry in the United States. This article delves into the complexities of the DSHEA Act, the nature of peptides, and their legal standing in the U.S. market.

What Exactly Are Peptides?

Before we can understand their legal classification, it's essential to know what peptides are. Peptides are short chains of amino acids, the building blocks of proteins. They occur naturally in the body and play crucial roles in a wide range of biological processes, acting as signaling molecules that instruct other cells and molecules on what to do. Some well-known examples of peptides include collagen, which is vital for skin health, and creatine, which is popular among athletes for its muscle-building properties.

While some peptides are derived from natural sources, many of the peptides that have gained popularity for their therapeutic potential are synthetic. These are created in a laboratory to mimic the functions of natural peptides, often with enhanced potency or stability. This distinction between natural and synthetic is a critical factor in their regulatory status.

Peptides can be categorized based on their size, function, and origin. Dipeptides consist of two amino acids, tripeptides have three, and so on. Polypeptides are longer chains of amino acids, and proteins are made up of one or more polypeptides. In terms of function, peptides can act as hormones, neurotransmitters, or have antimicrobial properties, among other things. For example, the peptide hormone insulin regulates blood sugar levels, while endorphins are peptides that act as natural painkillers.

When it comes to their origin, peptides can be sourced from food, such as collagen from bone broth, or they can be synthesized in a laboratory. The synthetic peptides are often designed to be more potent and stable than their natural counterparts, which makes them attractive for therapeutic use. However, it is this synthetic nature that often puts them at odds with the regulations governing dietary supplements.

Understanding the Dietary Supplement Health and Education Act (DSHEA)

The DSHEA Act of 1994 was a landmark piece of legislation that defined and regulated dietary supplements. Its primary purpose was to provide consumers with greater access to dietary supplements while also establishing a framework for the U.S. Food and Drug Administration (FDA) to ensure their safety. Under DSHEA, a dietary supplement is defined as a product intended to supplement the diet that contains one or more "dietary ingredients." These ingredients include:

Vitamins

Minerals

Herbs or other botanicals

Amino acids

Dietary substances for use by humans to supplement the diet by increasing the total dietary intake

A concentrate, metabolite, constituent, extract, or combination of any of the above

DSHEA also created a new category of ingredients called "new dietary ingredients" (NDIs). An NDI is a dietary ingredient that was not marketed in the United States before October 15, 1994. Manufacturers of supplements containing NDIs are required to notify the FDA at least 75 days before marketing their product and provide evidence that the ingredient is reasonably expected to be safe.

One of the most significant aspects of DSHEA is that it places the burden of proof for safety on the FDA, rather than the manufacturer. This means that, for the most part, dietary supplements do not require pre-market approval from the FDA. The agency can only take action to remove a product from the market if it can prove that it is unsafe. This is a key distinction from the regulation of drugs, which must undergo rigorous testing and receive FDA approval before they can be sold.

DSHEA also allows manufacturers to make certain claims about their products' effects on the body's structure or function. These are known as "structure/function" claims. For example, a supplement containing calcium can claim to "support strong bones." However, manufacturers are not allowed to make claims that their products can diagnose, treat, cure, or prevent any disease. If they do, the product is considered a drug and is subject to the FDA's drug regulations. Any product that carries a structure/function claim must also include a disclaimer that states the FDA has not evaluated the claim and that the product is not intended to "diagnose, treat, cure, or prevent any disease."

Are Peptides Dietary Supplements Under DSHEA?

The central question of whether peptides are dietary supplements under DSHEA is where the complexity arises. The answer largely depends on the origin and nature of the peptide. While the definition of a dietary ingredient includes amino acids, and peptides are chains of amino acids, the FDA has taken a more nuanced stance, particularly concerning synthetic peptides.

According to the FDA, for a substance to be considered a dietary ingredient, it must be a vitamin, mineral, herb or other botanical, amino acid, a dietary substance for use by man to supplement the diet by increasing the total dietary intake, or a concentrate, metabolite, constituent, extract, or combination of any of these. While some naturally occurring peptides found in food sources may fall under this definition, the vast majority of peptides marketed for therapeutic purposes are synthetic and do not have a history of being in the food supply prior to 1994. This places them in a regulatory gray area.

The FDA's Stance on Synthetic Peptides

The FDA has made it clear that synthetic peptides are generally not considered dietary supplements. The agency's position is that synthetic substances that were not marketed as dietary supplements or as food before October 15, 1994, are excluded from the definition of a dietary supplement. This means that most of the popular peptides used for performance enhancement, anti-aging, and other therapeutic purposes cannot be legally sold as dietary supplements.

Furthermore, if a peptide is approved as a new drug, licensed as a biologic, or authorized for clinical investigation, it is also excluded from the dietary supplement definition, unless it was previously marketed as a dietary supplement or food. This is often referred to as the "drug preclusion provision" of the FD&C Act.

The FDA has issued numerous warning letters to companies that have marketed synthetic peptides as dietary supplements. These letters often cite violations of the FD&C Act, including the sale of unapproved new drugs and misbranded products. For example, the FDA has taken action against companies selling peptides such as BPC-157 and TB-500, which have been promoted for uses such as injury recovery and performance enhancement. These actions underscore the agency's commitment to enforcing the law and protecting consumers from potentially harmful products.

It is also important to note that even if a peptide is derived from a natural source, it may still not qualify as a dietary ingredient if it has been chemically altered. The process of extracting and concentrating a peptide can sometimes change its chemical structure, which could render it a new, unapproved ingredient in the eyes of the FDA. This adds another layer of complexity to the regulation of peptides and highlights the importance of understanding the specific details of a product's manufacturing process.

| Category | Description | Legal Status | Examples |

| :--- | :--- | :--- | :--- |

| FDA-Approved Peptides | Peptides that have undergone rigorous testing and have been approved by the FDA for specific medical conditions. | Legal to prescribe and dispense for approved uses. | Insulin, Liraglutide |

| Research-Only Peptides | Peptides sold for laboratory and experimental use only, not for human consumption. | Illegal to market for human use. | BPC-157, TB-500 |

| Peptides in Dietary Supplements | Peptides, often synthetic, that are illegally marketed as dietary supplements. | Illegal to sell as dietary supplements. | Various anti-aging and muscle-building peptide supplements |

---

The specialists at TeleGenix can help you navigate the complexities of peptide therapy and determine if it's the right option for you. They can provide guidance on legally obtaining and using FDA-approved peptides for your specific health needs.

---

Navigating the Peptide Market

Given the complex regulatory landscape, it's crucial for consumers to be cautious when purchasing peptides. The market is flooded with products that are illegally marketed and may be unsafe. Here are some key points to keep in mind:

Be wary of products marketed as "peptide supplements." As discussed, most synthetic peptides cannot be legally sold as dietary supplements.

Look for FDA-approved peptides. If you are seeking peptide therapy for a medical condition, consult with a qualified healthcare provider who can prescribe FDA-approved peptides.

Avoid "research-only" peptides for personal use. These products are not intended for human consumption and may pose significant health risks.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.*

---

Related Articles